Drug-Material Interactions, Materials Selection, and Manufacturing Methods

[1]  L. Mermel,et al.  Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.

[2]  P. Fitzgerald,et al.  Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. , 2008, JAMA.

[3]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[4]  Lian Yu,et al.  Solubility of Small-Molecule Crystals in Polymers: d-Mannitol in PVP, Indomethacin in PVP/VA, and Nifedipine in PVP/VA , 2009, Pharmaceutical Research.

[5]  F. Ahmad,et al.  Validated stability-indicating densitometric thin-layer chromatography: application to stress degradation studies of minocycline. , 2007, Analytica chimica acta.

[6]  C. Dickman,et al.  Anterior Lumbar Interbody Fusion Using rhBMP-2 With Tapered Interbody Cages , 2002, Journal of spinal disorders & techniques.

[7]  Alfonso M. Gañán-Calvo,et al.  Generation of Steady Liquid Microthreads and Micron-Sized Monodisperse Sprays in Gas Streams , 1998 .

[8]  Arpita Tiwari,et al.  Effectiveness and Harms of Recombinant Human Bone Morphogenetic Protein-2 in Spine Fusion , 2013, Annals of Internal Medicine.

[9]  Benno J. Rensing,et al.  Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents: One-Year Angiographic and Intravascular Ultrasound Follow-Up , 2001, Circulation.

[10]  D. Untereker,et al.  Degradability of Polymers for Implantable Biomedical Devices , 2009, International journal of molecular sciences.

[11]  R. Reitz,et al.  DROP AND SPRAY FORMATION FROM A LIQUID JET , 1998 .

[12]  T. Elliott.  Role of antimicrobial central venous catheters for the prevention of associated infections. , 1999, The Journal of antimicrobial chemotherapy.

[13]  Giuseppe Musumeci,et al.  Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious? , 2004, Circulation.

[14]  Patrick W Serruys,et al.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy , 2004, The Lancet.

[15]  J. Peipert,et al.  Effectiveness of long-acting reversible contraception. , 2012, The New England journal of medicine.

[16]  J. Wilcox,et al.  Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design. , 2009, Journal of biomedical materials research. Part A.

[17]  R. M. Gale,et al.  A thermodynamic method of predicting the transport of steroids in polymer matrices , 1975 .

[18]  A. Manolis,et al.  Multi‐Center Clinical Experience with a Lumenless, Catheter‐Delivered, Bipolar, Permanent Pacemaker Lead: Implant Safety and Electrical Performance , 2006, Pacing and clinical electrophysiology : PACE.

[19]  J. Wilcox,et al.  Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent. , 2008, Journal of biomedical materials research. Part A.

[20]  S. Siegel,et al.  Effect of drug type on the degradation rate of PLGA matrices. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  R. Larsson,et al.  A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. , 1983, Biomaterials, medical devices, and artificial organs.

[22]  G. Stone,et al.  Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents: Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III Trial , 2009, Circulation.

[23]  C. Petta,et al.  A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants. , 2006, Human reproduction.

[24]  Robert Langer,et al.  Convergence in biomedical technology , 2006, Nature Biotechnology.

[25]  N. Kanuru,et al.  Implantation Success and Infection in Cardiovascular Implantable Electronic Device Procedures Utilizing an Antibacterial Envelope , 2011, Pacing and clinical electrophysiology : PACE.

[26]  A. Tzafriri,et al.  Luminal flow patterns dictate arterial drug deposition in stent-based delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[27]  H Yokoi,et al.  Three-year follow-up after implantation of metallic coronary-artery stents. , 1996, The New England journal of medicine.

[28]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[29]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[30]  William Wijns,et al.  Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. , 2007, Circulation.

[31]  N A Peppas,et al.  New challenges in biomaterials. , 1994, Science.

[32]  R. C. Thomson,et al.  Improvements in GORE-TEX 1 Vascular Graft Performance by Carmeda 1 BioActive Surface Heparin Immobilization , 2012 .

[33]  R. Tasker,et al.  Brodkey J: A Post-approval investigation of the infuse bone graft/LT-cage lumbar tapered fusion device for anterior Open and laparoscopic interbody fusion in patients with symptomatic degenerative disease. MEDTRONI. , 2004 .

[34]  D. B. Keenan,et al.  Accuracy of a New Real-Time Continuous Glucose Monitoring Algorithm , 2010, Journal of diabetes science and technology.

[35]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[36]  M. McGirt,et al.  Cerebrospinal shunt infection in patients receiving antibiotic-impregnated versus standard shunts. , 2011, Journal of neurosurgery. Pediatrics.

[37]  Gene A. Bornzin,et al.  A Steroid-Eluting, Low-Threshold, Low-Polarizing Electrode , 1983 .

[38]  L. Krach,et al.  Intrathecal Baclofen for Management of Spastic Cerebral Palsy: Multicenter Trial , 2000, Journal of child neurology.

[39]  O. Wenker,et al.  A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. , 1999, The New England journal of medicine.

[40]  Robert Langer,et al.  Advancing the field of drug delivery: taking aim at cancer. , 2003, Cancer cell.

[41]  P. Fitzgerald,et al.  Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions: Clinical and Angiographic Results of the ENDEAVOR II Trial , 2006, Circulation.

[42]  H Kalimo,et al.  Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. , 1997, Neurosurgery.

[43]  R Langer,et al.  New methods of drug delivery. , 1990, Science.

[44]  F. Boey,et al.  Release profiles in drug-eluting stents: issues and uncertainties. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Suming Li,et al.  Biodegradation of PLA/GA polymers: increasing complexity. , 1994, Biomaterials.

[46]  C. Henrikson,et al.  Mortality and cost associated with cardiovascular implantable electronic device infections. , 2011, Archives of internal medicine.

[47]  H. Kantarjian,et al.  Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  M. McGirt,et al.  Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. , 2005, Journal of neurosurgery.

[49]  H. C. Coelingh Bennink,et al.  Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. , 1998, Fertility and sterility.

[50]  Randall V. Sparer,et al.  Adjusting drug diffusivity using miscible polymer blends. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[51]  A. Farb,et al.  Stent thrombosis redux--the FDA perspective. , 2007, The New England journal of medicine.

[52]  H. Mond,et al.  The Electrode‐Tissue Interface: The Revolutionary Role of Steroid‐Elution , 2014, Pacing and clinical electrophysiology : PACE.

[53]  A. Yeung,et al.  Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial. , 2011, Journal of the American College of Cardiology.

[54]  R. J. Lang,et al.  Ultrasonic Atomization of Liquids , 1962 .